Peter A Thompson Insider Trading $ALPN ALPINE IMMUNE SCIENCES, INC.
Get free email notifications about insider trading for Peter A Thompson.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Peter A Thompson. Peter A Thompson is Director in RESPONSE BIOMEDICAL CORP ($RPBIF) and Director in ProNAi Therapeutics Inc ($DNAI) and President and CEO in Trubion Pharmaceuticals, Inc ($TRBN) and President, CEO & Treasurer in Trubion Pharmaceuticals, Inc ($TRBN) and Director in Synthorx, Inc. ($THOR) and Director in Adaptimmune Therapeutics PLC ($ADAP) and Director in ALPINE IMMUNE SCIENCES, INC. ($NVLS) and Director in Corvus Pharmaceuticals, Inc. ($CRVS) and Director in Decibel Therapeutics, Inc. ($DBTX) and Director in Silverback Therapeutics, Inc. ($SBTX) and Director in PMV Pharmaceuticals, Inc. ($PMVP) and Director in Prevail Therapeutics Inc. ($PRVL) and Director in Edgewise Therapeutics, Inc. ($EWTX).
Peter A Thompson in ALPINE IMMUNE SCIENCES, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Peter A Thompson: Director
Holdings: 3,070,955 shares
Current Value: $7,186,035
Latest Transaction: Dec 30 2020
$ALPN Market Capitalization: $36.22M
$ALPN Previous Close: $2.34
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Peter A Thompson in ALPINE IMMUNE SCIENCES, INC.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADAP, ALPN, CRVS, DBTX, EWTX, PMVP, PRVL, RPBIF, SRRA, SBTX, THOR, TRBN
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 30 2020 | ALPN | ALPINE IMMUNE SCIE ... | Thompson Peter A. | Director | Sell | S | 14.25 | 600,000 | 8,550,000 | 3,070,955 | 3.7 M to 3.1 M (-16.34 %) |
| Jan 06 2020 | ALPN | ALPINE IMMUNE SCIE ... | Thompson Peter A. | Director | Option Exercise | A | 3.62 | 7,650 | 27,718 | 7,650 | |
| Jan 23 2019 | ALPN | ALPINE IMMUNE SCIE ... | Thompson Peter A. | Director | Option Exercise | P | 0.00 | 145,251 | 0 | 145,251 | |
| Jan 23 2019 | ALPN | ALPINE IMMUNE SCIE ... | Thompson Peter A. | Director | Buy | P | 5.37 | 372,439 | 1,999,997 | 3,670,955 | 3.3 M to 3.7 M (+11.29 %) |
| Jan 04 2019 | ALPN | ALPINE IMMUNE SCIE ... | Thompson Peter A. | Director | Option Exercise | A | 4.09 | 7,650 | 31,289 | 7,650 | |
| Jan 04 2018 | NVLS | ALPINE IMMUNE SCIE ... | Thompson Peter A. | Director | Option Exercise | A | 11.31 | 7,650 | 86,522 | 7,650 | |
| Jul 26 2017 | NVLS | ALPINE IMMUNE SCIE ... | Thompson Peter A. | Director | Grant | A | 0.00 | 3,298,516 | 0 | 3,298,516 | 0 to 3.3 M |
Page: 1